why choose us

First received: March 28, 2023

Clinical Trial: A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction

Study Status: Completed

Recruit Status: RECRUITING

Condition: Breast Cancer

Study Type: INTERVENTIONAL


Official Title: A Randomized Controlled Trial of the Soluble Guanylate Cyclase Stimulator Vericiguat in Patients With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction (ELEVATE)

Brief Summary: The purpose of this study is to find out if adding vericiguat to standard treatment for cancer therapy related cardiac dysfunction (CTRCD) is more effective than standard treatment alone.The addition of vericiguat to the usual treatment could help improve cardiac function, but it could also cause side effects.This study will help researchers find out whether this different treatment is better, the same as, or worse than the usual approach.

Read more